col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


36 Ergebisse       Seite 1

 [1] 
Elsevier: Structure
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―29 A distinctive IGHV3-66 SARS-CoV-2 neutralizing antibody elicited by primary infection with an Omicron variant Qing Fan, Congcong Liu, Huimin Guo, Shilong Tang, Haiyan Wang, Bing Zhou, et al. (+6)
2 [GO] 2025―Apr―29 Structural insights into the receptor-binding domain of bat coronavirus ZXC21 Chenghai Wang, Xiaoyan Nan, Yang Deng, Shilong Fan, Xin Li, Jun Lan
3 [GO] 2025―Apr―11 Structural insights into the assembly and regulation of 2′-O RNA methylation by SARS-CoV-2 nsp16/nsp10 Anurag Misra, R. Rahisuddin, Manish Parihar, Shailee Arya, Thiruselvam Viswanathan, Nathaniel Jackson, et al. (+5)
4 [GO] 2024―Nov―13 The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity María Ángeles Márquez-Moñino, Clara M. Santiveri, Patricia de León, Sergio Camero, Ramón Campos-Olivas, M. Ángeles Jiménez, et al. (+3)
5 [GO] 2024―Nov―07 Multi-step shapeshifting of SARS-CoV-2 Omicron spikes during fusion Wang Xu, Yang Han, Maolin Lu
6 [GO] 2024―Okt―31 Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution Shuvankar Dey, Purba Pahari, Srija Mukherjee, James B. Munro, Dibyendu Kumar Das
7 [GO] 2024―Okt―03 Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution Shuvankar Dey, Purba Pahari, Srija Mukherjee, James B. Munro, Dibyendu Kumar Das
8 [GO] 2024―Sep―06 Structural review of SARS-CoV-2 antiviral targets Wen Cui, Yinkai Duan, Yan Gao, Wei Wang, Haitao Yang
9 [GO] 2024―Aug―22 Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike Helen M.E. Duyvesteyn, Aiste Dijokaite-Guraliuc, Chang Liu, Piyada Supasa, Barbara Kronsteiner, Katie Jeffery, et al. (+8)
10 [GO] 2024―Jul―15 Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants Linjie Li, Kaiyuan Shi, Yuhang Gu, Zepeng Xu, Chang Shu, Dedong Li, et al. (+11)
11 [GO] 2024―Jun―25 De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes Yan Zhu, Jiaolong Meng, Bo Feng, Yao Zhao, Yi Zang, Lingling Lu, et al. (+12)
12 [GO] 2024―Jan―15 Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1 Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, Rigel Suzuki, Atsushi Hoshino, Akira Noguchi, et al. (+16)
13 [GO] 2023―Dez―28 Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain Rajeshwer S. Sankhala, Vincent Dussupt, Wei-Hung Chen, Hongjun Bai, Elizabeth J. Martinez, Jaime L. Jensen, et al. (+39)
14 [GO] 2023―Okt―27 Review of serial femtosecond crystallography including the COVID-19 pandemic impact and future outlook Sabine Botha, Petra Fromme
15 [GO] 2023―Aug―24 SARS-CoV-2 fusion peptide sculpting of a membrane with insertion of charged and polar groups Steven R. Van Doren, Benjamin S. Scott, Rama K. Koppisetti
16 [GO] 2023―Jul―06 Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variant Meng Yuan, Ian A. Wilson
17 [GO] 2023―Mai―11 Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response Anamika Patel, Sanjeev Kumar, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Elluri Seetharami Reddy, et al. (+22)
18 [GO] 2023―Mrz―03 Molecular architecture and dynamics of SARS-CoV-2 envelope by integrative modeling Weria Pezeshkian, Fabian Grünewald, Oleksandr Narykov, Senbao Lu, Valeria Arkhipova, Alexey Solodovnikov, et al. (+3)
19 [GO] 2023―Feb―02 Order and disorder bound together in SARS-CoV-2 Nsp1 suppress host translation David S. Libich, Antoine Baudin
20 [GO] 2023―Jan―10 Room-temperature structural studies of SARS-CoV-2 protein NendoU with an X-ray free-electron laser Rebecca J. Jernigan, Dhenugen Logeswaran, Diandra Doppler, Nirupa Nagaratnam, Mukul Sonker, Jay-How Yang, et al. (+30)
21 [GO] 2023―Jan―06 Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2 Ying Wang, John Kirkpatrick, Susanne zur Lage, Teresa Carlomagno
22 [GO] 2022―Okt―06 Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2 Philipp Nawrath, Antoni G. Wrobel
23 [GO] 2022―Aug―01 Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2 Jun Lan, Peng Chen, Weiming Liu, Wenlin Ren, Linqi Zhang, Qiang Ding, et al. (+3)
24 [GO] 2022―Jun―17 Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection Kendra R. Vann, Arpan Acharya, Suk Min Jang, Catherine Lachance, Mohamad Zandian, Tina A. Holt, et al. (+7)
25 [GO] 2022―Jun―03 Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein Lorena Zuzic, Firdaus Samsudin, Aishwary T. Shivgan, Palur V. Raghuvamsi, Jan K. Marzinek, Alister Boags, et al. (+8)
26 [GO] 2022―Mai―23 Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity Anna Czarna, Jacek Plewka, Leanid Kresik, Alex Matsuda, Abdulkarim Karim, Colin Robinson, et al. (+9)
27 [GO] 2022―Mrz―10 Structural basis of nanobodies neutralizing SARS-CoV-2 variants Zhenzhong Shi, Xiyang Li, Lu Wang, Zengchao Sun, Haiwei Zhang, Xiaochen Chen, et al. (+10)
28 [GO] 2022―Jan―20 Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein Zhen Wah Tan, Wei-Ven Tee, Firdaus Samsudin, Enrico Guarnera, Peter J. Bond, Igor N. Berezovsky
29 [GO] 2021―Aug―16 Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing Serdar Durdagi, Çağdaş Dağ, Berna Dogan, Merve Yigin, Timucin Avsar, Cengizhan Buyukdag, et al. (+43)
30 [GO] 2021―Jun―22 Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease Maya G. Deshmukh, Joseph A. Ippolito, Chun-Hui Zhang, Elizabeth A. Stone, Raquel A. Reilly, Scott J. Miller, et al. (+2)
31 [GO] 2021―Jun―09 Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies Gabriele Cerutti, Micah Rapp, Yicheng Guo, Fabiana Bahna, Jude Bimela, Eswar R. Reddem, et al. (+8)
32 [GO] 2021―Apr―30 Conformational flexibility and structural variability of SARS-CoV2 S protein Ishika Pramanick, Nayanika Sengupta, Suman Mishra, Suman Pandey, Nidhi Girish, Alakta Das, Somnath Dutta
33 [GO] 2021―Apr―29 A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas, James M. Krieger, Asli Beyza Ozdemir, Gustavo Garcia, et al. (+4)
34 [GO] 2020―Okt―23 Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals Daniel W. Kneller, Stephanie Galanie, Gwyndalyn Phillips, Hugh M. O'Neill, Leighton Coates, Andrey Kovalevsky
35 [GO] 2020―Okt―15 The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET Chuang Liu, Luiza Mendonça, Yang Yang, Yuanzhu Gao, Chenguang Shen, Jiwei Liu, et al. (+17)
36 [GO] 2020―Aug―04 Structure of the Pandemic Sarah Kearns
 [1] 

36 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec